Compositions and methods for treating pancreatic cancer
DE10302421A1
New double-stranded interfering RNA, useful for inhibiting hepatitis C virus, has one strand linked to a lipophilic group to improve activity and eliminate the need for transfection auxiliaries
AU2002363182A1
Smad7 inhibitors for the treatment of cns diseases
EP1438406A1
Drug for treating a carcinoma of the pancreas
EP1438405A1
Use of a double-stranded ribonucleic acid for specifically inhibiting the expression of a given target gene
CN1608133A
Use of a double-stranded ribonucleic acid for treating an infection with a positivestrand rna-virus
WO03035869A1
Use of a double-stranded ribonucleic acid for specifically inhibiting the expression of a given target gene
WO03035870A1
Drug for treating a carcinoma of the pancreas
CN1604783A
Drug for treating a fibrotic disease through rna interfence
EP1438056A1
Drug for treating a fibrotic disease through rna interfence
EP1438409A1
Use of a double strand ribonucleic acid for treating an infection with a positive-strand rna-virus
CN1608131A
Drug for adenocarcinoma of pancreas
DE10230997A1
Drug to increase the effectiveness of a receptor-mediates apoptosis in drug that triggers tumor cells
DE10230996A1
Method for inhibiting viral replication, useful particularly for treating hepatitis C infection, by altering the 3'-untranslated region of the virus
DE10202419A1
Method of inhibiting expression of a target gene resulting from chromosome aberration
DE10160151A1
Inhibiting expression of target gene, useful e.g. for inhibiting oncogenes, by administering double-stranded RNA complementary to the target and having an overhang
DE10100587C1
Inhibiting expression of target genes, e.g. oncogenes, in cells, by introduction of complementary double-stranded oligoribonucleotide, after treating the cell with interferon
DE10100586C1
Inhibiting gene expression in cells, useful for e.g. treating tumors, by introducing double-stranded complementary oligoRNA having unpaired terminal bases
DE10100588A1
Inhibiting expression of target genes, useful e.g. for treating tumors, by introducing into cells two double-stranded RNAs that are complementary to the target
